On Tuesday, Shares of Pfizer Inc. (NYSE:PFE), gained 0.09% to $34.01.
Pfizer, declared that it has twelve presentations, counting new research data on tofacitinib for chronic plaque psoriasis and atopic dermatitis, at the forthcoming 23rd World Congress of Dermatology (WCD) meeting to be held on June 8-13 in Vancouver, Canada. Among the highlights are three late-breaking research presentations, counting 52-week pooled results from the Oral treatment Psoriasis Trials (OPT) Pivotal studies, an integrated safety summary across the OPT development program for oral tofacitinib, and the first presentation of two year results from OPT Extend, the ongoing long-term extension study of tofacitinib in moderate to severe chronic plaque psoriasis. In addition, new Phase 2a data for topical tofacitinib in the treatment of atopic dermatitis will be presented for the first time.
“We are proud of the data from the tofacitinib psoriasis clinical development program being presented at WCD as it adds to the body of evidence regarding the potential of tofacitinib as an additional oral treatment option for moderate to severe chronic plaque psoriasis,” said Rory O’Connor, senior vice president, Global Medical Affairs, Global Innovative Pharmaceuticals Business, Pfizer Inc. “The breadth and depth of the presentations at WCD underscores Pfizer’s leadership in oral Janus kinase (JAK) inhibition research.”
Pfizer continues to invest in the study of JAK inhibition across chronic inflammatory and immune-mediated diseases.
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments.
Shares of Nokia Corporation (NYSE:NOK), closed at $7.15, during its last trading session.
Los Angeles’ Nokia Theatre will now be known as the Microsoft Theater, according to AP.
Microsoft and theater owner AEG declared Tuesday that the 7,100-seat venue is being rebranded. Microsoft Corp. attained Nokia Corp.’s smartphone business last year.
The theater is in AEG’s L.A. Live entertainment and shopping complex in downtown Los Angeles, across from the Staples Center. AP Reports.
Nokia Corporation, together with its auxiliaries, provides network infrastructure and related services in Finland, the United States, Japan, China, India, the Russian Federation, Germany, Taiwan, Indonesia, Italy, and internationally.
Finally, SUPERVALU Inc. (NYSE:SVU), ended its last trade at the price of $8.47.
Supervalu Inc. paid Sam Duncan, its president and CEO, 40 percent more in fiscal 2015 than it did in the previous year, boosting his total compensation to $6.92 million, up from $4.95 million in 2014.
Duncan, 63, has been CEO and president of the grocery wholesaler and retailer since February 2013, when he took over for Wayne Sales, who had been CEO for just seven months. Sales remains a member of Supervalu’s board of directors. The CEO turnover at Supervalu drew a lot of attention to the company’s abundant executive and even director level compensation.
Duncan’s jump in pay this year was mainly a result of a large stock award he received for the company’s continued positive turnaround, which comprises improved same-store-sales, adjusted earnings and shareholder returns, among others metrics, according to the company’s proxy. Supervalu’s total market capitalization grew from $1.59 billion at the end of fiscal 2014 to $2.59 billion at the end of fiscal 2015. American City Business Journals States.
SUPERVALU INC., together with its auxiliaries, operates as a grocery wholesaler and retailer in the United States. The company operates through three segments: Independent Business, Save-A-Lot, and Retail Food.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.